Product development partnerships (PDPs) are generating an increasing flow of health products for diseases prevalent in developing countries. Based on past experience, ensuring end‐user access to these health products will present a significant challenge following the research and development process. The specific actions required to ensure access, and the time when these actions should be initiated, are becoming clearer based on the experiences to date in various PDPs. This list of activities can seem daunting, but the public health community is already learning how to spread these responsibilities between PDPs and other actors - both public and private, and international and national - such that efficiencies and local relevance are maximized.
Innovation Strategy Today (2010) 3 (1) 1-5